Ivan Ischenko serves as the Founder and Manager of Scientific Development at EpiCell Diagnostics, where he spearheads innovative initiatives at the intersection of epigenetics and liquid biopsy technology. With a strong foundation in research and development, Ivan has successfully initiated a clinically and commercially relevant...
Ivan Ischenko serves as the Founder and Manager of Scientific Development at EpiCell Diagnostics, where he spearheads innovative initiatives at the intersection of epigenetics and liquid biopsy technology. With a strong foundation in research and development, Ivan has successfully initiated a clinically and commercially relevant B2B2C start-up that aims to revolutionize individual health management through advanced diagnostic solutions. His role encompasses critical responsibilities such as securing funding, overseeing budget management, and promoting the company’s vision to a diverse audience.
Ivan's expertise in epigenetics research and market analysis enables him to stay ahead of industry trends and identify opportunities for growth. He collaborates cross-functionally with in vitro diagnostics (IVD) teams, laboratories, healthcare providers, and sales departments to ensure that EpiCell Diagnostics remains at the forefront of innovation. His ability to navigate complex regulatory environments while adhering to Good Clinical Practice (GCP) standards underscores his commitment to delivering high-quality products that meet the needs of patients and healthcare professionals alike.
In addition to his technical skills in oncology and biotechnology, Ivan’s multicultural background enhances his capacity for international communication and collaboration, allowing him to effectively engage with stakeholders from diverse backgrounds. His solution-focused mindset and exceptional organizational skills drive the successful execution of key projects, positioning EpiCell Diagnostics as a leader in the rapidly evolving landscape of personalized medicine. Through his work, Ivan Ischenko is not only advancing the field of epigenetics but also making significant contributions to the future of healthcare.
